Major histocompatibility complex (MHC) class I molecules promote the presentation of non-self antigens on cancer cell surface, favoring their immune recognition by CD8+ cytotoxic T lymphocytes: PC cells frequently downregulate MHC class I molecules to evade the immune detection [143,163,164,165,166,167,168]. This evidence concerns the gene CD8A and cancer.